Post-discharge mortality in the first wave of COVID-19 in Turkey

dc.authoridKöktürk, Nurdan/0000-0002-2889-7265
dc.authoridKetencioğlu, Burcu Baran/0000-0002-6757-3140
dc.authoridBAYDAR TOPRAK, OYA/0000-0001-7320-976X
dc.authoridyildiz gülhan, pinar/0000-0002-5347-2365
dc.authoridAkgün, Metin/0000-0003-3404-4274
dc.authoridGemicioglu, Bilun/0000-0001-5953-4881
dc.authoridFakılı, Füsun/0000-0002-1602-5240
dc.authorwosidKöktürk, Nurdan/AFS-1706-2022
dc.authorwosidKetencioğlu, Burcu Baran/AAO-9889-2021
dc.authorwosidyildiz gülhan, pinar/AAW-3004-2020
dc.authorwosidBAYDAR TOPRAK, OYA/U-9880-2018
dc.authorwosidAkgün, Metin/A-9993-2008
dc.authorwosidGemicioglu, Bilun/AAH-6927-2019
dc.authorwosidFakılı, Füsun/ABV-9256-2022
dc.contributor.authorFakılı, Füsun
dc.contributor.authorÇetinkaya, Pelin Duru
dc.contributor.authorBaydar, Oya
dc.contributor.authorArgun Barış, Serap
dc.contributor.authorKöktürk, Nurdan
dc.contributor.authorKul, Seval
dc.contributor.authorKarcıoğlu, Oğuz
dc.date.accessioned2023-07-26T11:50:46Z
dc.date.available2023-07-26T11:50:46Z
dc.date.issued2022
dc.departmentDÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Göğüs Hastalıkları Anabilim Dalıen_US
dc.description.abstractObjective: To determine post-discharge mortality and associated factors of the first-wave multicenter Turkish Thoracic Society (TTD)-TURCOVID study. Methods: In this retrospective cohort study, we analyzed the data of 18 of 26 centers included in the first TTD-TURCOVID study, and 1 112 cases diagnosed with COVID-19 between 11 March and 31 July 2020 participated in the study. All causes of death after COVID-19 discharge were recorded. Results: The mean age of the patients was (51.07 +/- 16.93) years, with 57.6% male patients. In the cohort group, 89.1% of COVID-19 treatment locations were hospital wards, 3.6% were intensive care units (ICUs), and 7.2% were community outpatients. In the long-term follow-up, the in-hospital mortality rate was 3.6% (95% CI 2.64.8), the post-discharge mortality rate was 2.8% (95% CI 1.9-3.9), and the total mortality was 6.3% (95% CI 5.0-7.8). After discharge, 63.3% of mortality overall occurred during the first six months. Mortality rates in post-discharge follow-ups were 12.7% (95% CI 8.0-30.6) in cancer patients, 10.8% (95% CI 6.3-22.9) in chronic obstructive pulmonary disease patients, 11.1% (95% CI 4.4-22.7) in heart failure patients, 7.8 (95% CI 3.8-14.3) in atherosclerotic heart disease patients, and 2.3% (95% CI 0.8-5.6) in diabetes mellitus patients. In smokers/ex-smokers, the all-mortality rates were higher than in non-smokers. Conclusions: This multicenter study showed that patients over 65 years of age, males, former/active smoker, ICU stay, lung, heart disease, and malignancy should be followed up for at least the first six months after discharge due to COVID-19.en_US
dc.identifier.doi10.4103/1995-7645.361853
dc.identifier.endpage484en_US
dc.identifier.issn1995-7645
dc.identifier.issn2352-4146
dc.identifier.issue11en_US
dc.identifier.scopus2-s2.0-85144982567en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage479en_US
dc.identifier.urihttps://doi.org/10.4103/1995-7645.361853
dc.identifier.urihttps://hdl.handle.net/20.500.12684/12425
dc.identifier.volume15en_US
dc.identifier.wosWOS:000893780600002en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.institutionauthorErçelik, Merve
dc.language.isoenen_US
dc.publisherWolters Kluwer Medknow Publicationsen_US
dc.relation.ispartofAsian Pacific Journal of Tropical Medicineen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.snmz$2023V1Guncelleme$en_US
dc.subjectCovid-19; Post-Discharge; Mortality; Comorbidityen_US
dc.titlePost-discharge mortality in the first wave of COVID-19 in Turkeyen_US
dc.typeArticleen_US

Dosyalar